某医院鲍曼不动杆菌临床分布及耐药性分析

Clinical Distribution and Drug Resistance Analysis of Acinetobacter Baumannii in a Hospital

为分析某医院鲍曼不动杆菌临床分布及耐药性情况,本文回顾性分析了2017年6月—2020年6月本院诊断为鲍曼不动杆菌的感染者111例,分析鲍曼不动杆菌临床科室分布情况,统计鲍曼不动杆菌标本来源分布情况及鲍曼不动杆菌耐药性分布情况。分布及耐药情况研究显示,呼吸科病房为最常见的菌株分布科室,其次为骨科病房和重症监护室(ICU);标本分布来源以痰液,尤其是下呼吸道分泌物最常见;耐药性研究显示,其对替加环素、妥布霉素和头孢哌酮/舒巴坦耐药性相对较低。由此可见,鲍曼不动杆菌在痰液标本检出率最高,好发于各科室,对于替加环素、妥布霉素和头孢哌酮/舒巴坦,经验用药可以考虑使用。

To analyze the clinical distribution and drug resistance of Acinetobacter baumannii in a hospital.A retrospective analysis of 111 patients diagnosed with Acinetobacter baumannii infection in our hospital from June 2017 to June 2020,analysis of the distribution of Acinetobacter baumannii in clinical departments,statistics of the source distribution of Acinetobacter baumannii specimens and Distribution of drug resistance of Acinetobacter baumannii.The distribution of 111 drug-resistant strains and the status of drug resistance found that the respiratory ward was the most common strain distribution department,followed by the orthopedic ward and the intensive care unit(ICU).The distribution source of specimens is sputum,especially lower respiratory tract secretions.In terms of drug resistance,its resistance to tigecycline,tobramycin and cefoperazone/sulbactam is relatively low.Acinetobacter baumannii has the highest detection rate in sputum samples,and it occurs in various departments.For tigecycline,tobramycin and cefoperazone/sulbactam,empirical medication can be considered.